STERIS plc STE
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-11-03
STERIS plc financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $5.5B | $5.1B | $4.5B | $4.2B |
| Gross profit | $2.6B | $2.4B | $2.2B | $2.0B | $1.9B |
| R&D expense | $112.9M | $107.6M | $103.7M | $98.5M | $86.7M |
| SG&A expense | $1.4B | $1.3B | $1.3B | $1.1B | $1.3B |
| Operating income | $1.1B | $866.6M | $836.1M | $791.1M | $477.8M |
| Interest expense | — | — | $144.4M | $108.0M | $89.5M |
| Income tax | $262.2M | $184.7M | $149.5M | $124.1M | $82.3M |
| Net income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M |
| EPS (diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
| Operating cash flow | $1.3B | $1.1B | $973.3M | $756.9M | $684.8M |
| Free cash flow | $972.4M | $778.0M | $613.0M | $395.0M | $397.2M |
| Cash & equivalents | — | $171.7M | $207.0M | $208.4M | $348.3M |
| Inventory | $631.8M | $581.3M | $674.5M | $604.4M | $575.0M |
| Total assets | $10.7B | $10.1B | $11.1B | $10.8B | $11.4B |
| Total liabilities | $3.5B | $3.5B | $4.7B | $4.7B | $4.9B |
| Shareholders' equity | $7.2B | $6.6B | $6.3B | $6.1B | $6.5B |
Source: SEC EDGAR filings · CIK 0001757898 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.